A mathematical model of Doxorubicin treatment efficacy for non-Hodgkin's lymphoma: investigation of the current protocol through theoretical modelling results.
Doxorubicin treatment outcomes for non-Hodgkin's lymphomas (NHL) are mathematically modelled and computationally analyzed. The NHL model includes a tumor structure incorporating mature and immature vessels, vascular structural adaptation and NHL cell-cycle kinetics in addition to Doxorubicin ph...
Autores principales: | Ribba, B, Marron, K, Agur, Z, Alarcón, T, Maini, P |
---|---|
Formato: | Journal article |
Lenguaje: | English |
Publicado: |
2005
|
Ejemplares similares
-
A mathematical model of Doxorubicin treatment efficacy on non-Hodgkin’s lymphoma: Investigation of current protocol through theoretical modelling results
por: Ribba, B, et al.
Publicado: (2005) -
The use of hybrid cellular automaton models for improving cancer therapy
por: Ribba, B, et al.
Publicado: (2004) -
The use of hybrid cellular automaton models for improving cancer therapy, In Proceedings, Cellular Automata: 6th International Conference on Cellular Automata for Research and Industry, ACRI 2004, Amsterdam, The Netherlands, eds P.M.A. Sloot, B. Chopard, A.G. Hoekstra
por: Ribba, B, et al.
Publicado: (2004) -
Current advances in Hodgkin’s lymphoma
por: Joseph Vadakara, et al.
Publicado: (2019-03-01) -
T064: Doxorubicin exposure and breast cancer risk in adolescent and adult Hodgkin lymphoma survivors
por: Suzanne I.M. Neppelenbroek, et al.
Publicado: (2022-10-01)